Distribution of eosinophil granule proteins in nasal mucosa of atopic patients with nasal polyposis

ORL

Volumn 58, Issue 2, 1996, Pages 82-86

  Min, Yang Gi ^a   Kim, Yong Jae ^b   Yun, Yeong Seok ^a  

^a Seoul National University   (South Korea)

^b National Medical Center   (South Korea)

Author keywords

Atopy; Eosinophil; Eosinophil granule protein; Immunohistochemical staining; Nasal polyp

Indexed keywords

PROTEIN;

ADULT; ALLERGIC RHINITIS; ARTICLE; ATOPY; AUDITORY CANAL; CELL INFILTRATION; CLINICAL ARTICLE; ENDOSCOPIC SURGERY; EOSINOPHIL; FACIAL BONE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NOSE MUCOSA; NOSE POLYP; PATHOGENESIS; PRIORITY JOURNAL; SAMPLE;

EID: 0029876337     PISSN: 03011569     EISSN: 14230275     Source Type: Journal    
DOI: 10.1159/000276804     Document Type: Article

References (15)

1. Ackerman SJ, Loegcring DA, Venge P, Olsson I, Harley JB, Fauci AS, Gleich GJ: Distinctive cationic proteins of the human eosinophil granule: Major basic protein, eosinophil cationic protein, eosinophil-derived ncurotoxin. J Immunol 1983;131:2977-2981.
2. Gleich GJ, Locgering DA, Bell MP, Checkel JL, Ackerman SJ, McKean DJ: Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein, homology with ribonuclcase. Proc Natl Acad Sei USA 1986;83:3146-3150.
3. Motojima S, Frigas E, Loegering DA, Gleich GJ: Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev RespirDis 1989;139:801-805.
4. Tai PC, Spry CJF, Peterson C, Venge P, Olsson I: Monoclonal antibodies distinguish between storage and secreted forms of eosinophilic cationic protein. Nature 1984;309:182-184.
5. Igarashi Y, Kaliner MA, Hausfcld JN, Irani AA, Schwartz LB, White MV: Quantification of resident inflammatory cells in the human nasal mucosa. J Allergy Clin Immunol 1993:91: 1082-1093.
6. Henocq E: PAF-acether and eosinophils. Prog Biochem Pharmacol 1988;22:141-148.
7. Holopainen E, Makinen J, Paavolainen M, Palva T, Salo OP: Nasal polyposis: Relationships to allergy and acetyl salicylic acid intolerance. Acta Otolaryngol (Stockh) 1979;87:330-334.
8. Bascom R, Pipkorn U, Proud D, Dunnrette S, Glcich GJ, Lichtenstein LM, Naclcrio RM: Major basic protein and eosinophil-derived neurotoxin concentration in nasal lavage fluid after antigen challenge: Effect of systemic corticosteroid and relationship to eosinophil influx. J Allergy Clin Immunol 1989;84:338-346.
9. Dc Monchy JGR, Kauffman HF, Venge P, Koeter GH, Jansen HM, Sluiter HK, deVries K: Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev RespirDis 1985;131:373-376.
10. Fukuda T, Gleich GJ: Heterogeneity of human eosinophils. J Allergy Clin Immunol 1989:83: 369-373.
11. Kakoi H, Hiraide F: A histological study of formation and growth of nasal polyps. Acta Otolaryngol (Stockh) 1987; 103:137-144.
12. Cockroft DW: Bronchial hyperresponsiveness: in Mygind N (ed): Rhinitis and Asthma: Similarities and Differences. Copenhagen, Munks-gaard, 1990, pp 172-202.
13. Jahnsen FL, Brandtzaeg P, Halstenscn TS: Monoclonal antibody F.G2 does not provide reliable immunohistochcmical distribution between resting and activated eosinophils. J Immunol Methods 1994;175:23-36.
14. Tai PC, Ackerman SJ, Spry CJF, Dunnette S, Olsen EGJ, Gleich GJ: Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 1987;i:643-647.
15. Stoop AE, Hameleers DMH, van Run PEM, Biewenga J, van der Baan S: Lymphocytes and nonlymphoid cells in the nasal mucosa of patients with nasal polyps and of healthy subjects. J Allergy Clin Immunol 1989;84:734-741.